Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells

BACKGROUND: Serine hydroxymethyltransferase 2 (SHMT2) is a key enzyme in one-carbon cell metabolism, including in liver cancer. However, the associations between SHMT2 expression at the gene and protein level and prognosis in patients with hepatocellular carcinoma (HCC) remains unknown. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Lijuan, Tang, Yuanyuan, Pang, Xumei, Zhang, Yingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691751/
https://www.ncbi.nlm.nih.gov/pubmed/31379360
http://dx.doi.org/10.12659/MSM.915754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691751/
https://www.ncbi.nlm.nih.gov/pubmed/31379360
http://dx.doi.org/10.12659/MSM.915754

Ejemplares similares